57
Views
5
CrossRef citations to date
0
Altmetric
Original Research

Silent myocardial infarction in women with type II diabetes mellitus and microalbuminuria

, , , , , & show all
Pages 705-712 | Published online: 08 Aug 2008

References

  • AbbottRDDonahueRPKannelWB1988The impact of diabetes on survival following myocardial infarction in men vs women. The Framingham StudyJAMA2603456602974889
  • AgewallMDPSWikstrandMDPJLjungmanMDPS1997Usefulness of microalbuminuria in predicting cardiovascular mortality in treated hypertensive men with and without diabetes mellitusAm J Cardiol8016499230153
  • BrohallGBehreCJHultheJ2006Prevalence of diabetes and impaired glucose tolerance in 64-year-old Swedish women: experiences of using repeated oral glucose tolerance testsDiabetes Care29363716443888
  • ChicoATomasANovialsA2005Silent myocardial ischemia is associated with autonomic neuropathy and other cardiovascular risk factors in type 1 and type 2 diabetic subjects, especially in those with microalbuminuriaEndocrine272131716230776
  • DavisTMFortunPMulderJ2004Silent myocardial infarction and its prognosis in a community-based cohort of Type 2 diabetic patients: the Fremantle Diabetes StudyDiabetologia47395914963648
  • Ebeling BarbierCBjernerTHansenT2007Clinically unrecognized myocardial infarction detected at MR imaging may not be associated with atherosclerosisRadiology2451031017717330
  • ElliottMDKimRJ2005Late gadolinium cardiovascular magnetic resonance in the assessment of myocardial viabilityCoron Artery Dis163657216118541
  • GokcelAAydinMYalcinF2003Silent coronary artery disease in patients with type 2 diabetes mellitusActa Diabetol401768014740277
  • HaffnerSM2000Coronary heart disease in patients with diabetesN Engl J Med3421040210749967
  • IbsenHOlsenMHWachtellK2006Does albuminuria predict cardiovascular outcomes on treatment with losartan versus atenolol in patients with diabetes, hypertension, and left ventricular hypertrophy? The LIFE studyDiabetes Care2959560016505512
  • KannelWBAbbottRD1984Incidence and prognosis of unrecognized myocardial infarction. An update on the Framingham studyN Engl J Med3111144476482932
  • KannelWBCupplesLAGagnonDR1990Incidence, precursors and prognosis of unrecognized myocardial infarctionAdv Cardiol37202142220449
  • KannelWBDannenbergALAbbottRD1985Unrecognized myocardial infarction and hypertension: the Framingham StudyAm Heart J109581853976481
  • KannelWBHjortlandMCastelliWP1974Role of diabetes in congestive heart failure: the Framingham studyAm J Cardiol3429344835750
  • KannelWBMcGeeDL1979Diabetes and cardiovascular disease. The Framingham studyJAMA24120358430798
  • KimRJWuERafaelA2000The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunctionN Engl J Med34314455311078769
  • KleinCNekollaSGBengelFM2002Assessment of myocardial viability with contrast-enhanced magnetic resonance imaging: comparison with positron emission tomographyCirculation105162711790695
  • KuhlHPLipkeCSKrombachGA2006Assessment of reversible myocardial dysfunction in chronic ischaemic heart disease: comparison of contrast-enhanced cardiovascular magnetic resonance and a combined positron emission tomography-single photon emission computed tomography imaging protocolEur Heart J278465316434414
  • Le FeuvreCLBarthelemyODubois-LaforgueD2005Stress myocardial scintigraphy and dobutamine echocardiography in the detection of coronary disease in asymptomatic patients with type 2 diabetesDiabetes Metab311354215959419
  • LundbladDEliassonM2003Silent myocardial infarction in women with impaired glucose tolerance: the Northern Sweden MONICA studyCardiovasc Diabetol2914498994
  • MiettinenHLehtoSSalomaaV1998Impact of diabetes on mortality after the first myocardial infarction. The FINMONICA Myocardial Infarction Register Study GroupDiabetes Care2169759538972
  • NeubauerS2000Cardiac magnetic resonance spectroscopy: potential clinical applicationsHerz254526010948781
  • NiskanenLTurpeinenAPenttilaI1998Hyperglycemia and compositional lipoprotein abnormalities as predictors of cardiovascular mortality in type 2 diabetes: a 15-year follow-up from the time of diagnosisDiabetes Care21186199802734
  • PoornimaIGParikhPShannonRP2006Diabetic cardiomyopathy: The search for a unifying hypothesisCirc Res9859660516543510
  • SandstedeJJ2003Assessment of myocardial viability by MR imagingEur Radiol13526112541110
  • Scheuermann-FreestoneMMadsenPLMannersD2003Abnormal cardiac and skeletal muscle energy metabolism in patients with type 2 diabetesCirculation1073040612810608
  • SheiferSEManolioTAGershBJ2001Unrecognized myocardial infarctionAnn Intern Med1358011111694105
  • SigurdssonEThorgeirssonGSigvaldasonH1995Unrecognized myocardial infarction: epidemiology, clinical characteristics, and the prognostic role of angina pectoris. The Reykjavik StudyAnn Intern Med122961027993002
  • SzczepaniakLSDobbinsRLMetzgerGJ2003Myocardial triglycerides and systolic function in humans: in vivo evaluation by localized proton spectroscopy and cardiac imagingMagn Reson Med494172312594743
  • WagnerAMahrholdtHHollyTA2003aContrast-enhanced MRI and routine single photon emission computed tomography (SPECT) perfusion imaging for detection of subendocardial myocardial infarcts: an imaging studyLancet361374912573373
  • WagnerAMahrholdtHSechtemU2003bMR imaging of myocardial perfusion and viabilityMagn Reson Imaging Clin N Am11496612797510
  • ValensiPPariesJBrulport-CerisierV2005Predictive value of silent myocardial ischemia for cardiac events in diabetic patients: influence of age in a French multicenter studyDiabetes Care282722716249546
  • YanoKMacLeanCJ1989The incidence and prognosis of unrecognized myocardial infarction in the Honolulu, Hawaii, Heart ProgramArch Intern Med1491528322742427